Glipizide: A Review of the Pharmacoeconomic Implications of the Extended-Release Formulation in Type 2 Diabetes Mellitus

Author： Foster R.H. Plosker G.L.

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.18, Iss.3, 2000-09, pp. : 289-306

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Exenatide Extended-Release: A Review of Its Use in Type 2 Diabetes Mellitus

By Scott Lesley J.

Drugs, Vol. 72, Iss. 12, 2012-08 ,pp. : 1679-1707

Adis International

Access to resources Recommend Favorite

Repaglinide: A Pharmacoeconomic Review of its Use in Type 2 Diabetes Mellitus

By Plosker G.L. Figgitt D.P.

PharmacoEconomics, Vol. 22, Iss. 6, 2004-01 ,pp. : 389-411

Adis International

Access to resources Recommend Favorite

Metformin extended release for the treatment of Type 2 diabetes mellitus

By Schwartz Sherwyn L Wu Jacqueline F Berner Bret

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 803-809

Informa Healthcare

Access to resources Recommend Favorite

Clinical development of metformin extended-release tablets for type 2 diabetes: an overview

By Schwartz Sherwin L Gordi Toufigh Hou Eddie Cramer Marilou Heritier Michelle Cowles Verne E

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 9, 2008-09 ,pp. : 1235-1243

Informa Healthcare

Access to resources Recommend Favorite

A Real-World Analysis of Persistence on and Adherence to Glipizide GITS, Glipizide IR and Glibenclamide in Managed Care among Patients with Type 2 Diabetes Mellitus

By Harley C.R.

Clinical Drug Investigation, Vol. 22, Iss. 9, 2002-01 ,pp. : 575-584

Adis International

Access to resources Recommend Favorite